Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Subscribe To Our Newsletter & Stay Updated
